March 13, 2018 / 8:11 PM / 6 months ago

BRIEF-Bellicum Pharmaceuticals Reports Qtrly Loss Per Share $0.66

March 13 (Reuters) - Bellicum Pharmaceuticals Inc:

* BELLICUM PHARMACEUTICALS PROVIDES OPERATIONAL UPDATE AND REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017

* ‍REMAINS ON TRACK TO FILE EUROPEAN MARKETING AUTHORIZATION APPLICATIONS FOR BPX-501 AND RIMIDUCID IN 2019​

* QTRLY LOSS PER SHARE $0.66‍​

* Q4 EARNINGS PER SHARE VIEW $-0.70 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below